Sector pending / Surgical and Medical Instruments and ApparatusUpdated 2026-05-10 22:07 UTC

XKON/336040 stock hub

XKON/336040 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

XKON/336040is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

23.7B

Korea New Exchange

Market data

Live price

Current market quote for this ticker.

Current price

XKON/336040

In the news

Latest news · XKON/336040

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-57.9

P25 n/aP50 n/aP75 n/a

ROIC-28.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All XKON/336040 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

144

Groups with data

Currency

KRW

Showing 144 of 144 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Exchange	Korea New Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Surgical and Medical Instruments and Apparatus
Last refreshed	2026-05-10
Market cap	KRW 23.7B
Price	KRW 4,140
Price currency	KRW
Sic	3841
Symbol	xkon/336040
Website	https://www.yidobio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.36%
FCF yield	-6.68%
P/B ratio	7.13x
P/S ratio	4.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-31.58%
EBITDA Margin	-21.88%
Gross margin	2.87%
Gross Profit	KRW 158.9M
Net Income	KRW -1.7B
Pretax Margin	-31.47%
Profit Margin	-31.47%
ROA	-17.75
ROCE	-47.3
ROE	-57.9
ROIC	-28.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-3.72%
Cagr3y	-27.77%
Cagr5y	-28.11%
Revenue Growth	84.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.9
Assets	KRW 7.5B
Cash	KRW 886.5M
Current Assets	KRW 5.4B
Current Liabilities	KRW 4.1B
Debt	KRW 553.6M
Debt Equity	KRW 0.17
Debt FCF	KRW -0.35
Equity	KRW 3.3B
Interest Coverage	-31.7
Liabilities	KRW 4.2B
Long Term Assets	KRW 2.1B
Long Term Liabilities	KRW 83.9M
Net Cash	KRW 332.9M
Net Cash By Market Cap	KRW 1.41
Net Debt Equity	KRW -0.1
Tangible Book Value	KRW 2.2B
Tangible Book Value Per Share	KRW 1,021
WACC	6.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.52
Inventory Turnover	5.28
Net Working Capital	KRW 1.4B
Quick ratio	1.01
Working Capital	KRW 2B

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-3.72%
200-day SMA	3,955.2
3Y total return	-62.33%
50-day SMA	4,057.2
50-day SMA vs 200-day SMA	50over200
5Y total return	-80.79%
All Time High	31,000
All Time High Change	-86.65%
All Time High Date	2021-07-08
All Time Low	2,400
All Time Low Change	72.5%
All Time Low Date	2025-12-23
ATR	199.8
Beta	0.48
Beta1y	-0.42
Beta2y	0.25
Ch YTD	38.23
High	4,140
High52	5,280
High52 Date	2025-11-05
High52ch	-21.59%
Low	4,140
Low52	2,400
Low52 Date	2025-12-23
Low52ch	72.5%
Ma50ch	2.04%
Price vs 200-day SMA	4.67%
RSI	51.38
RSI Monthly	42.99
RSI Weekly	53.55
Sharpe ratio	0.35x
Sortino ratio	0.6
Tr YTD	38.23
Tr1m	-1.43%
Tr1w	-1.31%
Tr3m	6.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -1.7B
Operating margin	-31.58

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,636,016%
Net Borrowing	-615,329,230
Shares Insiders	40.36%
Shares Institutions	46.89%
Shares Out	5,712,810
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -1.6B
Average Volume	14.55x
Bv Per Share	1,429.7
CAPEX	KRW -232.1M
Ch1m	-1.43
Ch1w	-1.31
Ch1y	-3.72
Ch3m	6.15
Ch3y	-62.33
Ch5y	-80.79
Ch6m	-15.51
Change	0.98%
Change From Open	0
Close	4,100
Days Gap	0.98
Depreciation Amortization	537,137,590
Dollar Volume	4,140
EBIT	KRW -1.7B
EBITDA	KRW -1.2B
EPS	KRW -824
F Score	1
FCF	KRW -1.6B
FCF Per Share	KRW -277
Financing CF	1,738,614,610
Fiscal Year End	December
Founded	2,014
Goodwill	741,804,450
Investing CF	-882,347,130
Is Primary Listing	1
Last Report Date	2019-06-30
Ma150	3,966.1
Ma150ch	4.38%
Ma20	4,121.3
Ma20ch	0.45%
Net CF	-492,178,410
Open	4,140
Ppne	524,482,250
Price Date	2026-05-08
Ptbv Ratio	10.96
Relative Volume	0.07x
Revenue	5,534,143,760x
Tr6m	-15.51%
Volume	1
Z Score	-0.7

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does XKON/336040 pay a dividend?

Capital-return profile for this ticker.

Performance

XKON/336040 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns XKON/336040?

Insider, institutional, and short-interest positioning.

Institutional ownership

+46.9%

Share of float held by funds and institutions

Insider ownership

+40.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

XKON/336040 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.4

Neutral momentum band

Price vs 200-day MA

+4.7%

50/200-day relationship not available

Beta (5Y)

0.48

Less volatile than the market

Sharpe ratio

0.35

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About XKON/336040

Hub-level FAQ points readers to the deeper analysis pages.

What is the current xkon/336040 stock rating?

xkon/336040 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full xkon/336040 analysis?

The full report lives at /stocks/xkon/336040/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for xkon/336040?

The latest report frames xkon/336040 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the xkon/336040 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.